Search Results - "Papi, Alberto"

THE AUTHORS REPLY.

Authors: LaForce, Craig Papi, Alberto Bacharier, Leonard B.

Source: New England Journal of Medicine. 10/30/2025, Vol. 393 Issue 17, p1756-1756. 1/3p.

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.

Authors: Tomaszewski, Erin L. Atkinson, Mark J. Janson, Christer et al.

Source: Respiratory Research. 6/27/2023, Vol. 24 Issue 1, p1-13. 13p.

Inhaled corticosteroids in severe COPD patients with cardiovascular diseases. Authors' reply.

Authors: Papi, Alberto Forini, Giacomo Maniscalco, Mauro et al.

Source: European Journal of Internal Medicine. Nov2024, Vol. 129, p131-132. 2p.

Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled Trials.

Authors: Bhatt, Surya P. Rabe, Klaus F. Hanania, Nicola A. et al.

Source: Pulmonary Therapy. Jun2026, p1-4. 4p.

Integrated Analysis of Parenchymal and Vascular HRCT Patterns with Circulating Biomarkers in Severe COVID-19 Pneumonia.

Authors: Carnevale, Aldo Morandi, Luca Scaramuzzo, Gaetano et al.

Source: Diagnostics (2075-4418). Feb2026, Vol. 16 Issue 4, p587. 15p.

Normalisation of airflow limitation in asthma: Post‐hoc analyses of TRIMARAN and TRIGGER.

Authors: Papi, Alberto Singh, Dave Virchow, J. Christian et al.

Source: Clinical & Translational Allergy. Apr2022, Vol. 12 Issue 4, p1-11. 11p.

Modeled reductions in COPD exacerbation rates, mortality, and related medical costs due to increased SITT adoption: PROMETHEUS Italy.

Authors: Santus, Pierachille Oresta, Bianca Finocchiaro, Davide et al.

Source: Respiratory Research. 10/28/2025, Vol. 26 Issue 1, p1-11. 11p.

Inhaled triple therapy in chronic obstructive pulmonary disease - Authors' reply.

Authors: Papi, Alberto Singh, Dave Petruzzelli, Stefano et al.

Source: Lancet. 9/29/2018, Vol. 392 Issue 10153, p1113-1114. 2p.

Retraction Note: The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide.

Authors: Perry, Mark M. Tildy, Bernadett Papi, Alberto et al.

Source: Respiratory Research. 8/25/2021, Vol. 22 Issue 1, p1-1. 1p.

Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS.

Authors: Price, David Henley, William Cançado, José Eduardo Delfini et al.

Source: Pragmatic & Observational Research. Jan2024, Vol. 15, p1-16. 16p.

Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.

Authors: Baraldo, Simonetta Bonato, Matteo Cassia, Sebastiano et al.

Source: Respiratory Research. 8/19/2024, Vol. 25 Issue 1, p1-11. 11p.

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial.

Authors: Papi, Alberto Nicolini, Gabriele Crimi, Nunzio et al.

Source: Respiratory Research. Jun2012, Vol. 13 Issue 6, p1-10. 10p. 1 Diagram, 3 Charts, 4 Graphs.

An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma.

Authors: El-Husseini, Zaid W. Khalenkow, Dmitry Lan, Andy et al.

Source: Respiratory Research. 12/7/2023, Vol. 24 Issue 1, p1-12. 12p.

Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection.

Authors: Yang, Chen Xi Tomchaney, Michael Landecho, Manuel F. et al.

Source: Cells (2073-4409). Jun2022, Vol. 11 Issue 12, p1864-N.PAG. 14p.

Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE).

Authors: Contoli, Marco Santus, Pierachille Menzella, Francesco et al.

Source: Clinical & Translational Allergy. Apr2022, Vol. 12 Issue 4, p1-10. 10p.

Global initiative for chronic obstructive lung disease 2023 report: Gold executive summary.

Authors: Agustí, Alvar Celli, Bartolome R. Criner, Gerard J. et al.

Source: Journal of the Pan African Thoracic Society. Sep-Dec2024, Vol. 5 Issue 3, p1-3. 3p.

Asthma COPD Overlap PRO-CON Debate. ACO: The Mistaken Term.

Authors: Papi, Alberto¹ (AUTHOR) ppa@unife.it

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease. Oct2020, Vol. 17 Issue 5, p474-476. 3p.

Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1.

Authors: Mumby, Sharon Perros, Frederic Grynblat, Julien et al.

Source: Respiratory Research. 7/29/2023, Vol. 24 Issue 1, p1-16. 16p.

Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.

Authors: Albers, Frank C. Papi, Alberto Taillé, Camille et al.

Source: Respiratory Research. 7/30/2019, Vol. 20 Issue 1, pN.PAG-N.PAG. 1p. 7 Diagrams, 1 Chart.

The Additional Value of Lower Respiratory Tract Sampling in the Diagnosis of COVID-19: A Real-Life Observational Study.

Authors: Morandi, Luca Torsani, Francesca Forini, Giacomo et al.

Source: Diagnostics (2075-4418). Oct2022, Vol. 12 Issue 10, p2372-N.PAG. 15p.